BDP8900
BDP8900 is a potent and selective inhibitor of myotonic dystrophy-related Cdc42-binding kinases (MRCKα and MRCKβ). BDP8900 reduces substrate phosphorylation, leading to morphological changes, motility inhibition and invasiveness of cancer cells.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2226507-05-5
- Formule: C19H23N5S
- Masse moléculaire:353.48
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
MRCKα |
MRCKβ |
Chemical Information
-
CAS No. 2226507-05-5
-
Masse moléculaire 353.48
-
Formule C19H23N5S
-
SMILES
N1(C2=CC=NC3=C2C(C4=NC=CS4)=CN3)C[C@]5(CCCCN5)CCC1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
BDP8900 Related Classifications
HY-111423 Related Classifications
Powered by Bioz